AC
Alexandria Capital Portfolio holdings
AUM
$1.08B
1-Year Return
29.48%
This Quarter Return
-0.02%
1 Year Return
+29.48%
3 Year Return
+66.93%
5 Year Return
+126.95%
10 Year Return
–
AUM
$1.08B
AUM Growth
+$1.59M
(+0.15%)
Cap. Flow
-$13.3M
Cap. Flow
% of AUM
-1.23%
Top 10 Holdings %
Top 10 Hldgs %
25.11%
Holding
268
New
3
Increased
97
Reduced
101
Closed
15
Top Buys
| 1 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
$1.56M |
| 2 |
SPDR Portfolio Short Term Treasury ETF
SPTS
|
$1.36M |
| 3 |
Johnson & Johnson
JNJ
|
$1.04M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
$887K |
| 5 |
SPDR Portfolio Aggregate Bond ETF
SPAB
|
$839K |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$656K |
| 2 |
iShares MSCI India Small-Cap ETF
SMIN
|
$582K |
| 3 |
Apple
AAPL
|
$487K |
| 4 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
$478K |
| 5 |
Nektar Therapeutics
NKTR
|
$430K |
Sector Composition
| 1 | Technology | 20.34% |
| 2 | Healthcare | 9.51% |
| 3 | Communication Services | 8.96% |
| 4 | Financials | 7.57% |
| 5 | Consumer Discretionary | 4.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.15B
| $785K | 0.07% |
7,621
| – | – |
|
152
Elanco Animal Health
ELAN
$9.16B
| $783K | 0.07% |
24,541
| – | – |
|
153
Invesco FTSE RAFI US 1000 ETF
PRF
$8.11B
| $764K | 0.07% |
24,115
-950
| -4% | -$30.1K |
|
154
Match Group
MTCH
$9.18B
| $749K | 0.07% |
4,774
+17
| +0.4% | +$2.67K |
|
155
American Airlines Group
AAL
$8.63B
| $718K | 0.07% |
35,012
| – | – |
|
156
Analog Devices
ADI
$122B
| $716K | 0.07% |
4,273
| – | – |
|
|
ATVI
157
DELISTED
Activision Blizzard Inc.
ATVI
| $716K | 0.07% |
9,253
| – | – |
|
158
Norfolk Southern
NSC
$62.3B
| $712K | 0.07% |
2,974
-200
| -6% | -$47.9K |
|
159
Emerson Electric
EMR
$74.6B
| $702K | 0.07% |
7,455
+140
| +2% | +$13.2K |
|
160
Charter Communications
CHTR
$35.7B
| $693K | 0.06% |
953
| – | – |
|
161
McDonald's
MCD
$224B
| $684K | 0.06% |
2,837
+409
| +17% | +$98.6K |
|
162
Novartis
NVS
$251B
| $681K | 0.06% |
8,323
+814
| +11% | +$66.6K |
|
163
Snap
SNAP
$12.4B
| $669K | 0.06% |
9,061
+714
| +9% | +$52.7K |
|
164
Union Pacific
UNP
$131B
| $665K | 0.06% |
3,391
+11
| +0.3% | +$2.16K |
|
165
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.22B
| $659K | 0.06% |
8,327
-123
| -1% | -$9.73K |
|
166
Ionis Pharmaceuticals
IONS
$9.76B
| $616K | 0.06% |
18,362
+65
| +0.4% | +$2.18K |
|
167
ASML
ASML
$307B
| $614K | 0.06% |
824
+7
| +0.9% | +$5.22K |
|
168
Stryker
SYK
$150B
| $614K | 0.06% |
2,329
| – | – |
|
169
iShares Russell 1000 Value ETF
IWD
$63.5B
| $588K | 0.05% |
3,754
-3
| -0.1% | -$470 |
|
170
Consolidated Edison
ED
$35.4B
| $573K | 0.05% |
7,894
-300
| -4% | -$21.8K |
|
171
Fiserv
FI
$73.4B
| $543K | 0.05% |
5,000
| – | – |
|
172
Garmin
GRMN
$45.7B
| $538K | 0.05% |
3,460
-200
| -5% | -$31.1K |
|
173
Chubb
CB
$111B
| $533K | 0.05% |
3,070
| – | – |
|
174
Pfizer
PFE
$141B
| $506K | 0.05% |
11,775
+394
| +3% | +$16.9K |
|
175
ScottsMiracle-Gro
SMG
$3.64B
| $497K | 0.05% |
3,395
-225
| -6% | -$32.9K |
|